Cisplatin resistance in cyclic AMP-dependent protein kinase mutants

Pharmacology and Therapeutics

Volumn 78, Issue 2, 1998, Pages 115-128

  Cvijic, M E ^a   Yang, W L ^a   Chin, K V ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

cAMP dependent protein kinase; Cisplatin; DNA repair; Drug resistance; Regulatory subunit

Indexed keywords

CAFFEINE; CISPLATIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DNA; METHYLXANTHINE;

CANCER; CANCER CHEMOTHERAPY; DNA REPAIR; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE INDUCTION; GROWTH REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032080026     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00002-3     Document Type: Review

References (105)

1. Abraham, I., Hunter, R. J., Sampson, K. E., Smith, S., Gottesman, M. M. and Mayi, J. K. (1987) Cyclic AMP-dependent protein kinase regulates sensitivity of cells to multiple drugs. Mol. Cell. Biol. 7: 3098-3106.
2. Abraham, I., Chin, K.-V., Gottesman, M. M., Mayo, J. K. and Sampson, K. E. (1990) Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of p-glycoprotein. Exp. Cell Res. 189: 133-141.
3. Alaoui-Jamali, M., Loubaba, B. B., Robyn, S., Tapiero, H. and Batist, G. (1994) Effect of DNA-repair-enzyme modulators on cytotoxicity of L-phenylalanine mustard and cis-diamminedichloroplatinum (II) in mammary carcinoma cells resistant to alkylating drugs. Cancer Chemother. Pharmacol. 34: 153-158.
4. Amieux, P. S., Cummings, D. E., Motamed, K., Brandon, E., Wailes, L. A., Le, K., Idzerda, R. L. and McKnight, G. S. (1997) Compensatory regulation of RIα protein levels in protein kinase A mutant mice. J. Biol. Chem. 272: 3993-3998.
5. Andrew, P. A. and Howell, S. B. (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2: 35-43.
6. Ariza, R. R., Keyse, S. M., Moggs, J. G. and Wood, R. D. (1996) Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts. Nucl. Acids Res. 24: 433-440.
7. Beavo, J. A. and Reifsnyder, D. H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11: 150-155.
8. Beebe, S., Oyen, O., Sandberg, M., Froysa, A., Hansson, V. and Jahnsen, T. (1990) Molecular cloning of a tissue-specific protein kinase (Cγ) from human testis - representing a third isoform of the catalytic subunit of cAMP-dependent protein kinase. Mol. Endocrinol. 4: 465-475.
9. Bellon, S. F., Coleman, J. H. and Lippard, S. J. (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum (II). Biochemistry 30: 8026-8035.
10. Boynton, A. L. and Whitfield, J. F. (1983) The role of cyclic AMP in cell proliferation: a critical assessment of the evidence. Adv. Cycl. Nucleotide Res. 15: 193-294.
11. Bradbury, A. W., Carter, D. C., Miller, W. R., Cho-Chung, Y. S. and Clair, T. (1994) Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. Br. J. Cancer 69: 738-742.
12. Brandon, E. P., Zhuo, M., Huang, Y., Qi, M., Gerhold, K. A., Burton, A. B., Kandel, E. R., McKnight, G. S. and Idzerda, R. L. (1995) Hippocampal long-term depression and depotentiation are defective in mice carrying a targeted disruption of the gene encoding the RIβ subunit of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 92: 8851-8855.
13. Brown, S. J., Kellet, P. J. and Lippard, S. J. (1993) Ixr, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261: 603-605.
14. Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E. and Lippard, S. J. (1992) Isolation and characterization of human cDNA clones encoding a high mobility group protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl. Acad. Sci. USA 89: 2307-2311.
15. Busse, P. M., Bose, S. K., Jones, R. W. and Tolmach, L. J. (1978) The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray induced killing during G2 arrest. Radiat. Res. 76: 292-307.
16. Butcher, R. W. and Sutherland, E. W. (1962) Adenosine 3′,5′-phosphate in biological materials. J. Biol. Chem. 237: 1244-1250.
17. Capecchi, M. R. (1994) Targeted gene replacement. Sci. Am. 270: 52-59.
18. Chin, K.-V., Chauhan, S. S., Abraham, I., Sampson, K. E., Krolczyk, A. J., Wong, M., Schimmer, B., Pastan, I. and Gottesman, M. M. (1992) Reduced mRNA levels for the multidrug resistance genes in cAMP-dependent protein kinase mutant cell lines. J. Cell. Physiol. 152: 87-94.
19. Cho-Chung, Y. S. (1990) Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res. 50: 7093-7100.
20. Cho-Chung, Y. S. and Clair, T. (1993) The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol. Ther. 60: 265-288.
21. Cho-Chung, Y. S., Clair, T., Tortora, G. and Yokozaki, H. (1991) Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol. Ther. 50: 1-33.
22. Cho-Chung, Y. S., Pepe, S., Clair, T., Budillon, A. and Nesterova, M. (1995) cAMP-dependent protein ldnase: role in normal and malignant growth. Crit. Rev. Oncol./Hematol. 21: 33-61.
23. Chrivia, J. C., Uhler, M. D. and McKnight, G. S. (1988) Characterization of genomic clones encoding for the Cα and Cβ subunits of mouse cAMP-dependent protein kinase. J. Biol. Chem. 263: 5739-5744.
24. Chu, G. (1994) Cellular responses to cisplatin: the roles of DNA-binding proteins and DNA repair. J. Biol. Chem. 269: 787-790.
25. Chu, G. and Chang, E. (1990) Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc. Natl. Acad. Sci. USA 87: 3324-3327.
26. Chu, G., Mantin, R., Shen, Y., Baskett, G. and Sussman, H. (1993) Massive cisplatin overdose by accidental substitution for carboplatin. Cancer 72: 3707-3714.
27. Ciccarelli, R. B., Solomon, M. J., Varshavsky, A. and Lippard, S. J. (1985) In vivo effector of cis-and trans-diamminedichloroplatinum (II) on SV40 chromosomes: differential repair, DNA-protein cross-linking and inhibition of replication. Biochemistry 24: 7533-7540.
28. Clegg, C. H., Cadd, G. G. and McKnight, G. S. (1988) Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 85: 3703-3707.
29. Coghlan, V. M., Perrino, B. A., Howard, M., Langeberg, L. K., Hicks, J. B., Gallatin, W. M. and Scott, J. D. (1995) Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267: 108-111.
30. Constantinou, A. I., Squinto, S. P. and Jungmann, R. A. (1985) The phosphoform of the regulatory subunit RII of cyclic AMP-dependent protein kinase possesses intrinsic topoisomerase activity. Cell 42: 429-437.
31. Cummings, D. E., Brandon, E. P., Planas, J. V., Motamed, K., Idezerda, R. L. and McKnight, G. S. (1996) Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A. Nature 382: 622-626.
32. Cvijic, M. E. and Chin, K. V. (1997a) Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin. Int. J. Cancer 72: 345-350.
33. Cvijic, M. E. and Chin, K. V. (1997b) Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cell Growth Differ. 8: 1243-1247.
34. Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V. A., Egwuagu, C. and Reed, E. (1992) ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst. 84: 1512-1517.
35. Daniel, V., Litwack, G. and Tomkins, G. (1973) Induction of cytolysis of culture lymphoma cells by adenosine 3′:5′-cyclic monophosphate and the isolation of resistant variants. Proc. Natl. Acad. Sci. USA 70: 76-79.
36. Doherty, P. J., Tsao, J. and Schimmer, B. P. (1982) Alteration of the regulatory subunit of type I cAMP-dependent protein kinase in mutant Y1 adrenal cells resistant to 8-bromoadenosine 3′:5′-monophosphate. J. Biol. Chem. 257: 5877-5883.
37. Eastman, A. and Schulte, N. (1988) Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum (II). Biochemistry 27: 4730-4734.
38. Evian, D., Gottesman, M., Pastan, I. and Anderson, W. B. (1979) A mutation affecting the catalytic subunit of cyclic AMP-dependent protein kinase CHO cells. J. Biol. Chem. 254: 6931-6937.
39. Foulkes, N. S. and Sassone-Cors, P. (1996) Transcription factors coupled to the cAMP-signalling pathway. Biochim. Biophys, Acta 1288: F101-F121.
40. Francis, S. H. and Corbin, J. (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol. 56: 237-272.
41. Gentleman, S., Russell, P., Hemmings, B. A. and Chader, G. J. (1989) Abnormal expression of the RI subunit of cyclic AMP-dependent protein kinase in Y-79 retinoblastoma celts. Exp. Eye Res. 48: 497-507.
42. Gergely, P. and Bot, G. (1977) The control of phosphorylase phosphatase by cAMP-dependent protein kinase. FEBS Lett. 82: 269-272.
43. Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C. and Anderson, M. E. (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA 89: 3070-3074.
44. Gonzalez, G. A. and Montminy, M. R. (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680.
45. Gosse, M. E., Padmanabhan, A., Fleischmann, R. D. and Gottesman, M. M. (1993) Expression of Chinese hamster cAMP-dependent protein kinase in Escherichia coli results in growth inhibition of bacterial cells: a model for the rapid screening of mutant type 1 regulatory subunit. Proc. Natl. Acad. Sci. USA 90: 8159-8163.
46. Gottesman, M. M. and Fleishman, R. D. (1986) The role of cAMP in regulating tumor cell growth. Cancer Surv. 5: 291-308.
47. Gottesman, M. M., LeCam, A., Bukowski, M. and Pastan, I. (1980) Isolation of multiple classes of mutants of CHO cells resistant to cyclic AMP. Somat. Cell Genet. 6: 45-61.
48. Heiger-Bernays, W. J., Essigmann, J. M. and Lippard, S. J. (1990) Effect of the antitumor drug cis-diamminedichloroplatinum (II) and related platinum complexes on eukaryotic DNA replication. Biochemistry 29: 8461-8466.
49. Howell, S. B., Vick, J., Andrews, P. A., Velury, S. and Sanga, S. (1987) Dipyridamole: biochemical modulation of cisplatin. In: Proceedings of the Fifth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, pp. 228-234, Marino, N. (ed.) Martinus Nijoff Publishing, Padua.
50. Huang, Y., Kandel, E. R., Varshavsky, L., Branden, E. P., Qi, M., Idezerda, R. L., McKnight, G. S. and Bourtchouladze, R. (1995) A genetic test of the effects of mutation in PKA on mossy fiber LTP and its regulation to spatial and contextual learning. Cell 83: 1211-1222.
51. Insel, P. A., Bourne, H. R., Coffino, P. and Tomkins, G. M. (1975) Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth. Science 190: 896-898.
52. Jahnsen, T., Hedin, L., Kidd, V. J., Beattie, W. G., Lohman, S. M., Walter, U., Durica, J., Schultz, T. Z., Schiltz, E., Browner, M., Lawrence, G. B., Goldman, D., Ratoosh, S. L. and Richards, J. S. (1986) Molecular cloning, cDNA structure, and regulation of the regulatory subunit of type II cAMP-dependent protein kinase from rat ovarian granulose cells. J. Biol. Chem. 261: 12352-12361.
53. Johnson, G. S., Freidman, R. M. and Pastan, I. (1971) Restoration of several morphological characteristics of normal fibroblasts in sarcoma cells treated with adenosine-3′:5′-cyclic monophosphate and its derivatives. Proc. Natl. Acad. Sci. USA 68: 425-429.
54. Jones, J. C., Zhen, W., Reed, E., Parker, R. J., Sancar, A. and Bohr, V. A. (1991) Gene specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem. 266: 7101-7107.
55. Katsaros, D., Tortora, G., Tagliaferri, P., Clair, T., Ally, S., Neckers, L., Robins, P. K. and Cho-Chung, Y. S. (1987) Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth. FEBS Lett. 223: 97-103.
56. Keane, T. E., Rosner, G., Donaldson, J., Norwood, D. L., Poulton, S. H. and Walther, P. J. (1990) Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xencgraft models of human testicular and bladder cancers. J. Urol. 144: 1004-1009.
57. Khatra, B. S., Printz, R., Cobb, C. E. and Corbin, J. D. (1985) Regulatory subunit of cAMP-dependent protein kinase inhibits phosphoprotein phosphatase. Biochem. Biophys. Res. Commun. 130: 567-572.
58. Krebs, E. G. and Beavo, J. A. (1979) Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48: 923-959.
59. Lalli, E. and Sassone-Corsi, P. (1994) Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269: 17359-17362.
60. Lau, C. C. and Pardee, A. B. (1982) Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc. Natl. Acad. Sci. USA 79: 2942-2946.
61. Lee, D. C., Carmichael, D. F., Krebs, E. G. and McKnight, G. S. (1983) Isolation of a cDNA clone for the type I regulatory subunit of bovine cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 80: 3608-3612.
62. Link, C. J., Jr., Evans, M. K., Cool, J. A., Muldoon, R., Stevensner, T. and Bohr, V. A. (1995) Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cell and in human xeroderma pigmentosum group C cells. Carcinogenesis 16: 1149-1155.
63. Liu, B., Cvijic, M. E., Jetzt, A. and Chin, K.-V. (1996) Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants. Cell Growth Differ. 7: 1105-1112.
64. Mann, S. C., Andrews, P. A. and Howell, S. B. (1991) Modulation of cis-diamminedichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine insensitive and resistant human ovarian carcinoma cells. Int. J. Cancer 48: 866-872.
65. McA'Nulty, M. M. and Lippard, J. J. (1996) The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat. Res. 362: 75-86.
66. McKnight, G. S. (1991) Cyclic AMP second messenger systems. Curr. Opin. Cell Biol. 3: 213-217.
67. Mellon, P. L., Clegg, C. H., Correll, L. A. and McKnight, G. S. (1989) Regulation of transcription by cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 86: 4887-4891.
68. Miller, W. R., Hulme, M. J., Cho-Chung, Y. S. and Elton, R. A. (1993a) Types of cyclic AMP binding proteins in human breast cancer. Eur. J. Cancer Part A: Gen. Topics 29: 989-991.
69. Miller, W. R., Watson, D. M. A., Jack, W., Chetty, U. and Elton, R. A. (1993b) Tumor cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat. 26: 89-94.
70. Nishio, K., Morikage, T., Kubota, N., Ohmori, T., Takeda, Y., Fujiwara, Y., Miki, K., Abe, K. and Saijo, N. (1992) Alteration of type II regulatory subunit of cAMP-dependent protein kinase in human cisplatin-resistant cells as a basis of collateral sensitivity to 8-chloro-cAMP. Jpn. J. Cancer Res. 83: 754-760.
71. North, P. S., Davies, S. L., Ciardiello, F., Damiano, V., Bianco, C., Pepe, S., Bianco, A. R., Harris, A. L., Hickson, I. D. and Tortora, G. (1994) Overexpression of the RIα subunit of protein kinase A confers hypersensitivity to topoisomerase II inhibitors and 8-chloro-cyclic adenosine 3′,5′-monophosphate in Chinese hamster ovary cells. Cancer Res. 54: 4123-4128.
72. O'Dwyer, P. J., Johnson, S. W. and Hamilton, T. C. (1997) Cisplatin and its analogues. In: Cancer: Principles and Practice of Oncology, 5th ed., pp. 418-432, DeVita, V. T., Jr., Hellman, S. and Rosenberg, S. A. (eds.) Lippincott-Raven Publishers, Philadelphia.
73. Olson, M. F., Krolczyk, A. J., German, K. B., Steinberg, R. A. and Schimmer, B. P. (1993) Molecular basis for the 3′,5′-cyclic adenosine monophosphate resistance of Kin 8 mutant Y1 adrenocortical tumor cells. Mol. Endocrinol. 7: 477-487.
74. Parker, R. J., Eastman, A., Bostick-Bruton, F. and Reed, E. (1991) Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J. Clin. Invest. 87: 772-777.
75. Pil, P. M. and Lippard, S. J. (1992) Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science 256: 234-237.
76. Rae, P. A., Gutmann, N. S., Tsao, J. and Schimmer, B. P. (1979) Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis. Proc. Natl. Acad. Sci. USA 76: 1896-1900.
77. Rauth, A. M. (1967) Evidence for dark-reactivation of ultraviolet light damage in mouse L cells. Radiat. Res. 31: 121-138.
78. Rice, J. A., Crothers, D. M., Pinto, A. L. and Lippard, S. J. (1988) The major adduct of the antitumor drug cis-diamminedichloroplatinum (II) with DNA bends the duplex by = 40° toward the major groove. Proc. Natl. Acad. Sci. USA 85: 4158-4161.
79. Scala, S., Budillon, A., Zhan, Z., Cho-Chung, Y. S., Jefferson, J., Tsokos, M. and Bates, S. E. (1995) Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells. J. Clin. Invest. 96: 1026-1034.
80. Scanlon, K. J., Kashane-Sabat, M., Tone, T. and Funato, T. (1991) Cisplatin resistance in human cancers. Pharmacol. Ther. 52: 385-406.
81. Schimmer, B. P., Tsao, J. and Knapp, M. (1977) Isolation of mutant adrenocortical tumor cell resistant to cyclic nucleotides. Mol. Cell. Endocrinol. 8: 135-145.
82. Scott, J. D., Glaccum, M. B., Zoller, M. J., Uhler, M. D., Holfman, D. M., McKnight, G. S. and Krebs, E. G. (1987) The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. Proc. Natl. Acad. Sci. USA 84: 5192-5196.
83. Selby, C. P. and Sancar, A. (1990) Molecular mechanisms of DNA repair inhibition by caffeine. Proc. Natl. Acad. Sci. USA 87: 3522-3525.
84. Sheibani, N., Jennerwein, M. M. and Eastman, A. (1989) DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum (II): host cell reactivation of damaged plasmid DNA. Biochemistry 28: 3120-3124.
85. Singh, T. J., Roth, C., Gottesman, M. M. and Pastan, I. (1981) Characterization of cyclic AMP-resistant Chinese hamster ovary cell mutants lacking type I protein kinase. J. Biol. Chem. 256: 926-932.
86. Singh, T. J., Hochman, J., Verna, R., Chapman, M., Abraham, I., Pastan, I. H. and Gottesman, M. M. (1985) Characterization of a cyclic AMP-resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinase. J. Biol. Chem. 260: 13927-13933.
87. Szymkowski, D. E., Yarema, K., Essigmann, J. M. and Lippard, S. J. (1992) An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc. Natl. Acad. Sci. USA 89: 10772-10776.
88. Teicher, B. A., Holden, S. A., Herman, T. S., Epelbaum, R., Pardee, A. B. and Dezube, B. (1991) Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res. 11: 1555-1560.
89. Timmer-Bosscha, H., Mulder, N. H. and de Vries, E. G. E. (1992) Modulation of cis-diaminedichloroplatinum (II) resistance: a review. Br. J. Cancer 66: 227-238.
90. Tortora, G., Yokozaki, H., Pepe, S., Clair, T. and Cho-Chung, Y. S. (1991) Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 88: 2011-2015.
91. Tortora, G., Pepe, S., Bianco, C., Baldassarre, G., Budillon, A., Clair, T., Cho-Chung, Y. S., Bianco, A. R. and Ciardiello, F. (1994a) The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene 9: 3233-3240.
92. Tortora, G., Pepe, S., Bianco, C., Damiano, V., Ruggiero, A., Baldassarre, G., Corbo, C., Cho-Chung, Y. S., Bianco, A. R. and Ciardiello, F. (1994b) Differential effects of protein kinase A subunits on Chinese hamster ovary cell cycle and proliferation. Int. J. Cancer 59: 712-716.
93. Tortora, G., Damiano, V., Bianco, C., Baldassarre, G., Bianco, A. R., Lanfrancone, L., Pelicci, P. G. and Ciardiello, F. (1997) The Riot subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene 14: 923-928.
94. cdc2 protein kinase in human fibroblasts. J. Biol. Chem. 266: 19018-19022.
95. Van Lookeren Champagne, M. M., Wu, E., Fleischmann, R. D., Gottesman, M. M., Chason, K. W. and Kessin, R. H. (1990) Cyclic AMP responses are suppressed in mammalian cells expressing the yeast low Km cAMP-phosphodiesterase gene. J. Biol. Chem. 265: 5840-5846.
96. Walker, I. G. and Reid, B. D. (1971) Caffeine potentiation of the lethal action of alkylating agents on L-cells. Mutat. Res. 12: 101-104.
97. Waud, W. R. (1987) Differential uptake of cis-diammtnedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells. Cancer Res. 47: 6549-6555.
98. Weber, I. T., Takio, K., Titani, K. and Steitz, T. A. (1982) The cAMP-binding domains of the regulatory subunit of cAMP-dependent protein kinase and the catabolite gene activator protein are homologous. Proc. Natl. Acad, Sci. USA 79: 7679-7683.
99. Wu, J. C. and Wang, J. H. (1989) Sequence-selective DNA binding to the regulatory subunit of cAMP-dependent protein kinase. J. Biol. Chem. 264: 9989-9993.
100. Yokozaki, H., Tortora, G., Pepe, S., Maronde, E., Genieser, H. G., Jastroff, B. and Cho-Chung, Y. S. (1992) Unhydrolyzable analogues of adenosine 3′:5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 52: 2504-2508.
101. Yokozaki, H., Budillon, A. and Tortora, G. (1993) An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res. 53: 868-872.
102. Zamble, D. B. and Lippard, S. J. (1995) Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci. 20: 435-439.
103. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A. and Lippard, S. J. (1996) Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry 35: 10004-10013.
104. Zhen, W., Link, C. J., O'Connor, P. M., Read, E., Parker, R., Howell, S. B. and Bohr, V. A. (1992) Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Biol. 12: 3689-3698.
105. Zhong, H., Yang, H. S., Erdjument-Bromage, H., Tempst, P. and Ghosh, S. (1997) The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.